Your browser doesn't support javascript.
loading
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
Schoretsanitis, Georgios; Dubath, Céline; Grosu, Claire; Piras, Marianna; Laaboub, Nermine; Ranjbar, Setareh; Ansermot, Nicolas; Crettol, Séverine; Vandenberghe, Frederik; Gamma, Franziska; von Gunten, Armin; Plessen, Kerstin Jessica; Seifritz, Erich; Conus, Philippe; Eap, Chin B.
Afiliação
  • Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
  • Dubath C; Department of Psychiatry, Northwell Health, The Zucker Hillside Hospital, New York, New York, USA.
  • Grosu C; Department of Psychiatry, Zucker School of Medicine at Northwell/Hofstra, Hempstead, New York, USA.
  • Piras M; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Laaboub N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Ranjbar S; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Ansermot N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Crettol S; Center for Psychiatric Epidemiology and Psychopathology, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Vandenberghe F; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Gamma F; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • von Gunten A; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Plessen KJ; Les Toises Psychiatry and Psychotherapy Center, Lausanne, Switzerland.
  • Seifritz E; Service of Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Conus P; Service of Child and Adolescent Psychiatry, Department of Psychiatry, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Eap CB; Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
Basic Clin Pharmacol Toxicol ; 130(4): 531-541, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35150056

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Basic Clin Pharmacol Toxicol Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça